Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
|Videos|December 4, 2022
Part 1: Alternatives to hysterectomy & uterine-preserving options for fibroids
Author(s)Lindsey Carr, Editor
Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.
Advertisement
Advertisement
Related to this article
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Neurokinin receptor antagonists improve menopausal sleep disturbance
2
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
3
Higher physical activity tied to lower perimenopause symptom burden
4
How misread WHI data reshaped menopause care and training
5